X-47169430-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 3P and 2B. PM2PP2BP4_Moderate
The NM_005676.5(RBM10):c.133C>A(p.Pro45Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000182 in 1,097,876 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_005676.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RBM10 | NM_005676.5 | c.133C>A | p.Pro45Thr | missense_variant | 3/24 | ENST00000377604.8 | NP_005667.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RBM10 | ENST00000377604.8 | c.133C>A | p.Pro45Thr | missense_variant | 3/24 | 1 | NM_005676.5 | ENSP00000366829 | A1 | |
RBM10 | ENST00000329236.8 | c.328C>A | p.Pro110Thr | missense_variant | 3/24 | 1 | ENSP00000328848 | P3 | ||
RBM10 | ENST00000628161.2 | c.133C>A | p.Pro45Thr | missense_variant | 3/23 | 1 | ENSP00000486115 | |||
RBM10 | ENST00000345781.10 | c.133C>A | p.Pro45Thr | missense_variant | 3/23 | 2 | ENSP00000329659 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD3 exomes AF: 0.0000110 AC: 2AN: 182281Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 66827
GnomAD4 exome AF: 0.00000182 AC: 2AN: 1097876Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 363238
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 27, 2022 | The c.133C>A (p.P45T) alteration is located in exon 3 (coding exon 2) of the RBM10 gene. This alteration results from a C to A substitution at nucleotide position 133, causing the proline (P) at amino acid position 45 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 12, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. This variant has not been reported in the literature in individuals affected with RBM10-related conditions. This variant is present in population databases (rs782797549, gnomAD 0.005%). This sequence change replaces proline, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 45 of the RBM10 protein (p.Pro45Thr). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at